Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

OBJECTIVES: To prospectively investigate in patients with severe COVID-19-associated cytokine storm syndrome (CSS) whether an intensive course of glucocorticoids with or without tocilizumab accelerates clinical improvement, reduces mortality and prevents invasive mechanical ventilation, in compariso...

詳細記述

保存先:
書誌詳細
出版年:Ann Rheum Dis
主要な著者: Ramiro, Sofia, Mostard, Rémy L M, Magro-Checa, César, van Dongen, Christel M P, Dormans, Tom, Buijs, Jacqueline, Gronenschild, Michiel, de Kruif, Martijn D, van Haren, Eric H J, van Kraaij, Tom, Leers, Mathie P G, Peeters, Ralph, Wong, Dennis R, Landewé, Robert B M
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2020
主題:
Epidemiology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456552/
https://ncbi.nlm.nih.gov/pubmed/32719045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2020-218479
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料